Jenscare Scientific Co., Ltd. (HKG:9877)
Hong Kong
· Delayed Price · Currency is HKD 8.43
+0.42 (5.24%)
Mar 10, 2026, 3:54 PM HKT
Jenscare Scientific Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Cash & Equivalents | 495.41 | 605.99 | 927.83 | 727.36 | 800.59 | 349.07 |
| Short-Term Investments | - | 16.82 | 9.85 | 1.94 | 1.85 | - |
| Trading Asset Securities | 35.42 | - | 166.44 | 97.75 | - | - |
| Cash & Short-Term Investments | 530.83 | 622.81 | 1,104 | 827.05 | 802.44 | 349.07 |
| Cash Growth | -35.46% | -43.59% | 33.50% | 3.07% | 129.88% | - |
| Accounts Receivable | 6.26 | 9.31 | - | 0.68 | 0.53 | 0.05 |
| Other Receivables | - | - | - | - | - | 0.01 |
| Receivables | 6.26 | 9.31 | - | 0.68 | 0.53 | 0.07 |
| Inventory | 36.63 | 35.65 | 28.13 | 9.89 | 4.67 | 1.52 |
| Other Current Assets | 74.18 | 18.09 | 22.67 | 17.73 | 21.17 | 4.53 |
| Total Current Assets | 647.9 | 685.86 | 1,155 | 855.36 | 828.81 | 355.19 |
| Property, Plant & Equipment | 196.08 | 194.24 | 138.55 | 71.89 | 20.46 | 10.42 |
| Long-Term Investments | 71.89 | 101.54 | - | 483.73 | 467.56 | - |
| Other Intangible Assets | 4.02 | 4.01 | 4.14 | 4.19 | 2.39 | 0.47 |
| Other Long-Term Assets | 47.89 | 41.92 | 29.49 | 16.16 | 22.14 | 6.78 |
| Total Assets | 967.77 | 1,028 | 1,327 | 1,431 | 1,341 | 372.84 |
| Accounts Payable | 15.61 | 12.51 | 16.94 | 11.75 | 8.66 | 4.07 |
| Accrued Expenses | - | 12.68 | 18.73 | 15.94 | 11.58 | 5.67 |
| Short-Term Debt | - | 4.36 | - | - | - | 0.61 |
| Current Portion of Long-Term Debt | 38.43 | 11.66 | - | - | - | - |
| Current Portion of Leases | 2.18 | 1.99 | 1.92 | 2.31 | 1.34 | 1.21 |
| Current Unearned Revenue | 13.74 | 13.28 | 11.88 | 11.68 | 11.48 | 6.68 |
| Other Current Liabilities | 25.7 | 7.72 | 9.22 | 15.06 | 16.65 | 0.12 |
| Total Current Liabilities | 95.66 | 64.2 | 58.68 | 56.74 | 49.7 | 18.36 |
| Long-Term Debt | 15.76 | 44.29 | 40.75 | - | - | - |
| Long-Term Leases | 1.24 | 2.12 | 1.41 | 1.57 | 1.07 | 1.7 |
| Total Liabilities | 112.66 | 110.61 | 100.84 | 58.3 | 50.77 | 20.06 |
| Common Stock | 417.17 | 417.17 | 417.17 | 417.17 | 409.09 | 19.62 |
| Additional Paid-In Capital | 1,238 | 1,238 | 1,238 | 1,215 | 1,034 | 440.25 |
| Retained Earnings | -1,653 | -1,483 | -1,306 | -934.18 | -494.86 | -384.89 |
| Treasury Stock | -26.54 | -132.29 | -5.04 | - | - | - |
| Comprehensive Income & Other | 895.33 | 892.65 | 888.99 | 675.52 | 343.02 | 277.81 |
| Total Common Equity | 870.64 | 931.76 | 1,233 | 1,373 | 1,291 | 352.78 |
| Minority Interest | -15.53 | -14.81 | -6.62 | -0.26 | -0.16 | - |
| Shareholders' Equity | 855.1 | 916.95 | 1,226 | 1,373 | 1,291 | 352.78 |
| Total Liabilities & Equity | 967.77 | 1,028 | 1,327 | 1,431 | 1,341 | 372.84 |
| Total Debt | 57.61 | 64.42 | 44.08 | 3.87 | 2.41 | 3.53 |
| Net Cash (Debt) | 473.22 | 558.39 | 1,060 | 823.18 | 800.03 | 345.54 |
| Net Cash Growth | -38.10% | -47.32% | 28.77% | 2.90% | 131.53% | - |
| Net Cash Per Share | 1.16 | 1.37 | 2.54 | 2.25 | 2.36 | 1.24 |
| Filing Date Shares Outstanding | 417.17 | 417.17 | 417.17 | 417.17 | 364.35 | 278.71 |
| Total Common Shares Outstanding | 417.17 | 417.17 | 417.17 | 417.17 | 364.35 | 278.71 |
| Working Capital | 552.24 | 621.65 | 1,096 | 798.62 | 779.11 | 336.83 |
| Book Value Per Share | 2.09 | 2.23 | 2.96 | 3.29 | 3.54 | 1.27 |
| Tangible Book Value | 866.62 | 927.75 | 1,229 | 1,369 | 1,288 | 352.32 |
| Tangible Book Value Per Share | 2.08 | 2.22 | 2.95 | 3.28 | 3.54 | 1.26 |
| Machinery | - | 45.5 | 41.84 | 34.94 | 16.82 | 8.47 |
| Construction In Progress | - | 147.27 | 80.86 | 12.42 | 1.01 | 1.25 |
| Leasehold Improvements | - | 15.05 | 13.8 | 12.92 | 11.08 | 6.08 |
Source: S&P Capital IQ. Standard template. Financial Sources.